Two Sigma Investments
ARKG icon

Two Sigma Investments’s ARK Genomic Revolution ETF ARKG Stock Holding History

Two Sigma Investments’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-47,800
Closed -$1.26M – 5052
2026
Q1 		$1.26M Sell
47,800
-169,900
-78% -$4.98M ﹤0.01% 3081
2025
Q4 		$6.31M Buy
217,700
+190,300
+695% +$5.71M 0.01% 1504
2025
Q3 		$761K Sell
27,400
-97,800
-78% -$2.47M ﹤0.01% 2756
2025
Q2 		$3.05M Buy
+125,200
New +$2.74M 0.01% 1548
2025
Q1 		– Sell
-961,500
Closed -$22.6M – 3192
2024
Q4 		$22.6M Buy
961,500
+829,200
+627% +$20.4M 0.05% 440
2024
Q3 		$3.39M Buy
132,300
+14,100
+12% +$359K 0.01% 1311
2024
Q2 		$2.78M Sell
118,200
-98,600
-45% -$2.49M 0.01% 1333
2024
Q1 		$6.24M Sell
216,800
-217,500
-50% -$6.54M 0.01% 858
2023
Q4 		$14.2M Buy
+434,300
New +$11.8M 0.03% 537
2023
Q2 		– Sell
-20,800
Closed -$625K – 2995
2023
Q1 		$625K Buy
+20,800
New +$645K ﹤0.01% 2102

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Two Sigma Investments's ARKG Position: Q2 2026 in Review

Two Sigma Investments sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2026, closing a stake of 47,800 shares — an estimated $1.26M sold.

Two Sigma Investments first reported a position in ARKG in Q1 2023 and held it in 10 quarters. The position peaked at $22.6M in Q4 2024. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Two Sigma Investments reported no remaining ARK Genomic Revolution ETF position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Investments sold 47,800 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.26M.
  • Two Sigma Investments first reported a position in ARK Genomic Revolution ETF in Q1 2023 and held it in 10 quarters.
  • Two Sigma Investments's ARK Genomic Revolution ETF position peaked at $22.6M in Q4 2024.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.